while people die.
The FDA could hold an emergency meeting to extend vaccine eligibility to 5-11 year olds, but anti-virals that could save patients wait until the scheduled Nov 30 meeting for consideration.
Merck and Pfizer have pills that can cut deaths to near zero. Studies were cut short to get them into use ASAP.
But the FDA can’t be rushed.
Could it be that they just don’t want people to have alternatives to vaccination?
Is this an exception to Hanlon’s Razor?